As of August 20, 2026, the CDC has confirmed 2,777 measles cases in the United States for the year, already exceeding the full-year 2025 total of 2,289 and marking the highest annual count since 1991. Recent weekly additions have accelerated sharply, with 211 new cases reported in the latest update, concentrated in Pennsylvania and Ohio outbreaks where most infections involve unvaccinated or unknown-status individuals (94% overall). The highly contagious virus (basic reproduction number typically 12–18) spreads rapidly in susceptible communities amid declining MMR coverage, with 36 active outbreaks driving 94% of cases and 7% hospitalization rates but no deaths to date. Back-to-school timing and ongoing surveillance could influence transmission through September 30, as CDC releases weekly provisional data that directly inform case thresholds.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · AggiornatoCasi di morbillo negli Stati Uniti entro il 30 settembre?
Casi di morbillo negli Stati Uniti entro il 30 settembre?
NUOVO
30 set 2026
2900+
98%
3000+
93%
$1,252 Vol.
2900+
$940 Vol.
98%
3000+
$313 Vol.
93%
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of August 20, 2026, the CDC has confirmed 2,777 measles cases in the United States for the year, already exceeding the full-year 2025 total of 2,289 and marking the highest annual count since 1991. Recent weekly additions have accelerated sharply, with 211 new cases reported in the latest update, concentrated in Pennsylvania and Ohio outbreaks where most infections involve unvaccinated or unknown-status individuals (94% overall). The highly contagious virus (basic reproduction number typically 12–18) spreads rapidly in susceptible communities amid declining MMR coverage, with 36 active outbreaks driving 94% of cases and 7% hospitalization rates but no deaths to date. Back-to-school timing and ongoing surveillance could influence transmission through September 30, as CDC releases weekly provisional data that directly inform case thresholds.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Mercato aperto: Aug 24, 2026, 11:00 AM ET
Volume
$1,252Data di fine
30 set 2026Mercato aperto
Aug 24, 2026, 11:00 AM ETResolver
0x65070BE91...This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.As of August 20, 2026, the CDC has confirmed 2,777 measles cases in the United States for the year, already exceeding the full-year 2025 total of 2,289 and marking the highest annual count since 1991. Recent weekly additions have accelerated sharply, with 211 new cases reported in the latest update, concentrated in Pennsylvania and Ohio outbreaks where most infections involve unvaccinated or unknown-status individuals (94% overall). The highly contagious virus (basic reproduction number typically 12–18) spreads rapidly in susceptible communities amid declining MMR coverage, with 36 active outbreaks driving 94% of cases and 7% hospitalization rates but no deaths to date. Back-to-school timing and ongoing surveillance could influence transmission through September 30, as CDC releases weekly provisional data that directly inform case thresholds.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by September 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.
Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$1,252Data di fine
30 set 2026Mercato aperto
Aug 24, 2026, 11:00 AM ETResolver
0x65070BE91...As of August 20, 2026, the CDC has confirmed 2,777 measles cases in the United States for the year, already exceeding the full-year 2025 total of 2,289 and marking the highest annual count since 1991. Recent weekly additions have accelerated sharply, with 211 new cases reported in the latest update, concentrated in Pennsylvania and Ohio outbreaks where most infections involve unvaccinated or unknown-status individuals (94% overall). The highly contagious virus (basic reproduction number typically 12–18) spreads rapidly in susceptible communities amid declining MMR coverage, with 36 active outbreaks driving 94% of cases and 7% hospitalization rates but no deaths to date. Back-to-school timing and ongoing surveillance could influence transmission through September 30, as CDC releases weekly provisional data that directly inform case thresholds.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · Aggiornato
Fai attenzione ai link esterni.
Fai attenzione ai link esterni.
Domande frequenti